Gunma, Japan

Naomi Wakabayashi

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 4 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Kyoto University, Other. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naomi Wakabayashi. Retrieved from https://idiyas.com/inventor/naomi-wakabayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0


 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Hyogo, JP (2014)
  • Gunma, JP (2010 - 2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Naomi Wakabayashi: Innovator in Physiologically Active Peptides

Introduction

Naomi Wakabayashi is a prominent inventor based in Gunma, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of liquid preparations for physiologically active peptides. With a total of 4 patents, her work focuses on enhancing the bioavailability of important peptides and proteins used in medical applications.

Latest Patents

Wakabayashi's latest patents include a groundbreaking liquid preparation of physiologically active peptides. This innovative formulation achieves high bioavailability of peptides, such as ghrelins, which are administered as drugs. The preparation includes a physiologically active peptide or protein, an acid solution, an alcohol, and a polar organic liquid. This combination is designed to improve the bioavailability of these peptides when injected subcutaneously in aqueous solutions.

Another notable patent involves motilin-like peptide compounds that possess enhanced transmucosal absorbability. These compounds maintain the gastrointestinal motility stimulating activity of native motilin while being adapted for higher absorbability upon transmucosal administration. The design and synthesis of these motilin derivatives take into account the degradation pathways of motilin, ensuring that they retain their physiological activity.

Career Highlights

Throughout her career, Naomi Wakabayashi has worked with esteemed organizations, including Daiichi Sankyo Company, Limited. Her expertise in biochemistry and peptide research has positioned her as a leading figure in her field.

Collaborations

Wakabayashi has collaborated with notable colleagues such as Seiji Sato and Takeshi Hanada. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Naomi Wakabayashi's contributions to the field of physiologically active peptides highlight her role as a significant inventor. Her innovative patents and collaborations reflect her dedication to advancing medical science through her research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…